[1]
Huang KW, Liu TC, Liang RY, Chu LY, Cheng HL, Chu JW, Hsiao YY. Structural basis for overhang excision and terminal unwinding of DNA duplexes by TREX1. PLoS biology. 2018 May:16(5):e2005653. doi: 10.1371/journal.pbio.2005653. Epub 2018 May 7
[PubMed PMID: 29734329]
[2]
Lindahl T, Gally JA, Edelman GM. Properties of deoxyribonuclease 3 from mammalian tissues. The Journal of biological chemistry. 1969 Sep 25:244(18):5014-9
[PubMed PMID: 5824576]
[3]
Perrino FW, Mazur DJ, Ward H, Harvey S. Exonucleases and the incorporation of aranucleotides into DNA. Cell biochemistry and biophysics. 1999:30(3):331-52
[PubMed PMID: 10403055]
[4]
Yan N. Immune Diseases Associated with TREX1 and STING Dysfunction. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research. 2017 May:37(5):198-206. doi: 10.1089/jir.2016.0086. Epub
[PubMed PMID: 28475463]
[5]
Mazur DJ, Perrino FW. Identification and expression of the TREX1 and TREX2 cDNA sequences encoding mammalian 3'--}5' exonucleases. The Journal of biological chemistry. 1999 Jul 9:274(28):19655-60
[PubMed PMID: 10391904]
[6]
Höss M, Robins P, Naven TJ, Pappin DJ, Sgouros J, Lindahl T. A human DNA editing enzyme homologous to the Escherichia coli DnaQ/MutD protein. The EMBO journal. 1999 Jul 1:18(13):3868-75
[PubMed PMID: 10393201]
[7]
Morita M, Stamp G, Robins P, Dulic A, Rosewell I, Hrivnak G, Daly G, Lindahl T, Barnes DE. Gene-targeted mice lacking the Trex1 (DNase III) 3'--}5' DNA exonuclease develop inflammatory myocarditis. Molecular and cellular biology. 2004 Aug:24(15):6719-27
[PubMed PMID: 15254239]
[8]
Crow YJ, Hayward BE, Parmar R, Robins P, Leitch A, Ali M, Black DN, van Bokhoven H, Brunner HG, Hamel BC, Corry PC, Cowan FM, Frints SG, Klepper J, Livingston JH, Lynch SA, Massey RF, Meritet JF, Michaud JL, Ponsot G, Voit T, Lebon P, Bonthron DT, Jackson AP, Barnes DE, Lindahl T. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus. Nature genetics. 2006 Aug:38(8):917-20
[PubMed PMID: 16845398]
[9]
Thomas CA, Tejwani L, Trujillo CA, Negraes PD, Herai RH, Mesci P, Macia A, Crow YJ, Muotri AR. Modeling of TREX1-Dependent Autoimmune Disease using Human Stem Cells Highlights L1 Accumulation as a Source of Neuroinflammation. Cell stem cell. 2017 Sep 7:21(3):319-331.e8. doi: 10.1016/j.stem.2017.07.009. Epub 2017 Aug 10
[PubMed PMID: 28803918]
[10]
Yang YG, Lindahl T, Barnes DE. Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell. 2007 Nov 30:131(5):873-86
[PubMed PMID: 18045533]
[11]
Zuo Y, Deutscher MP. Exoribonuclease superfamilies: structural analysis and phylogenetic distribution. Nucleic acids research. 2001 Mar 1:29(5):1017-26
[PubMed PMID: 11222749]
[12]
Hsiao YY, Fang WH, Lee CC, Chen YP, Yuan HS. Structural insights into DNA repair by RNase T--an exonuclease processing 3' end of structured DNA in repair pathways. PLoS biology. 2014 Mar:12(3):e1001803. doi: 10.1371/journal.pbio.1001803. Epub 2014 Mar 4
[PubMed PMID: 24594808]
[13]
Lindahl T, Barnes DE, Yang YG, Robins P. Biochemical properties of mammalian TREX1 and its association with DNA replication and inherited inflammatory disease. Biochemical Society transactions. 2009 Jun:37(Pt 3):535-8. doi: 10.1042/BST0370535. Epub
[PubMed PMID: 19442247]
[14]
Orebaugh CD, Fye JM, Harvey S, Hollis T, Perrino FW. The TREX1 exonuclease R114H mutation in Aicardi-Goutières syndrome and lupus reveals dimeric structure requirements for DNA degradation activity. The Journal of biological chemistry. 2011 Nov 18:286(46):40246-54. doi: 10.1074/jbc.M111.297903. Epub 2011 Sep 21
[PubMed PMID: 21937424]
[15]
Rice G, Patrick T, Parmar R, Taylor CF, Aeby A, Aicardi J, Artuch R, Montalto SA, Bacino CA, Barroso B, Baxter P, Benko WS, Bergmann C, Bertini E, Biancheri R, Blair EM, Blau N, Bonthron DT, Briggs T, Brueton LA, Brunner HG, Burke CJ, Carr IM, Carvalho DR, Chandler KE, Christen HJ, Corry PC, Cowan FM, Cox H, D'Arrigo S, Dean J, De Laet C, De Praeter C, Dery C, Ferrie CD, Flintoff K, Frints SG, Garcia-Cazorla A, Gener B, Goizet C, Goutieres F, Green AJ, Guet A, Hamel BC, Hayward BE, Heiberg A, Hennekam RC, Husson M, Jackson AP, Jayatunga R, Jiang YH, Kant SG, Kao A, King MD, Kingston HM, Klepper J, van der Knaap MS, Kornberg AJ, Kotzot D, Kratzer W, Lacombe D, Lagae L, Landrieu PG, Lanzi G, Leitch A, Lim MJ, Livingston JH, Lourenco CM, Lyall EG, Lynch SA, Lyons MJ, Marom D, McClure JP, McWilliam R, Melancon SB, Mewasingh LD, Moutard ML, Nischal KK, Ostergaard JR, Prendiville J, Rasmussen M, Rogers RC, Roland D, Rosser EM, Rostasy K, Roubertie A, Sanchis A, Schiffmann R, Scholl-Burgi S, Seal S, Shalev SA, Corcoles CS, Sinha GP, Soler D, Spiegel R, Stephenson JB, Tacke U, Tan TY, Till M, Tolmie JL, Tomlin P, Vagnarelli F, Valente EM, Van Coster RN, Van der Aa N, Vanderver A, Vles JS, Voit T, Wassmer E, Weschke B, Whiteford ML, Willemsen MA, Zankl A, Zuberi SM, Orcesi S, Fazzi E, Lebon P, Crow YJ. Clinical and molecular phenotype of Aicardi-Goutieres syndrome. American journal of human genetics. 2007 Oct:81(4):713-25
[PubMed PMID: 17846997]
[16]
Crow YJ, Rehwinkel J. Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity. Human molecular genetics. 2009 Oct 15:18(R2):R130-6. doi: 10.1093/hmg/ddp293. Epub
[PubMed PMID: 19808788]
[17]
Richards A, van den Maagdenberg AM, Jen JC, Kavanagh D, Bertram P, Spitzer D, Liszewski MK, Barilla-Labarca ML, Terwindt GM, Kasai Y, McLellan M, Grand MG, Vanmolkot KR, de Vries B, Wan J, Kane MJ, Mamsa H, Schäfer R, Stam AH, Haan J, de Jong PT, Storimans CW, van Schooneveld MJ, Oosterhuis JA, Gschwendter A, Dichgans M, Kotschet KE, Hodgkinson S, Hardy TA, Delatycki MB, Hajj-Ali RA, Kothari PH, Nelson SF, Frants RR, Baloh RW, Ferrari MD, Atkinson JP. C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nature genetics. 2007 Sep:39(9):1068-70
[PubMed PMID: 17660820]
[18]
Orebaugh CD, Fye JM, Harvey S, Hollis T, Wilkinson JC, Perrino FW. The TREX1 C-terminal region controls cellular localization through ubiquitination. The Journal of biological chemistry. 2013 Oct 4:288(40):28881-92. doi: 10.1074/jbc.M113.503391. Epub 2013 Aug 26
[PubMed PMID: 23979357]
[19]
de Silva U, Choudhury S, Bailey SL, Harvey S, Perrino FW, Hollis T. The crystal structure of TREX1 explains the 3' nucleotide specificity and reveals a polyproline II helix for protein partnering. The Journal of biological chemistry. 2007 Apr 6:282(14):10537-43
[PubMed PMID: 17293595]
[20]
Mazur DJ, Perrino FW. Excision of 3' termini by the Trex1 and TREX2 3'--}5' exonucleases. Characterization of the recombinant proteins. The Journal of biological chemistry. 2001 May 18:276(20):17022-9
[PubMed PMID: 11279105]
[21]
Nick McElhinny SA,Pavlov YI,Kunkel TA, Evidence for extrinsic exonucleolytic proofreading. Cell cycle (Georgetown, Tex.). 2006 May;
[PubMed PMID: 16687920]
[22]
Stetson DB, Ko JS, Heidmann T, Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell. 2008 Aug 22:134(4):587-98. doi: 10.1016/j.cell.2008.06.032. Epub
[PubMed PMID: 18724932]
[23]
Chowdhury D, Beresford PJ, Zhu P, Zhang D, Sung JS, Demple B, Perrino FW, Lieberman J. The exonuclease TREX1 is in the SET complex and acts in concert with NM23-H1 to degrade DNA during granzyme A-mediated cell death. Molecular cell. 2006 Jul 7:23(1):133-42
[PubMed PMID: 16818237]
[24]
Beresford PJ, Zhang D, Oh DY, Fan Z, Greer EL, Russo ML, Jaju M, Lieberman J. Granzyme A activates an endoplasmic reticulum-associated caspase-independent nuclease to induce single-stranded DNA nicks. The Journal of biological chemistry. 2001 Nov 16:276(46):43285-93
[PubMed PMID: 11555662]
[25]
Christmann M, Tomicic MT, Aasland D, Berdelle N, Kaina B. Three prime exonuclease I (TREX1) is Fos/AP-1 regulated by genotoxic stress and protects against ultraviolet light and benzo(a)pyrene-induced DNA damage. Nucleic acids research. 2010 Oct:38(19):6418-32. doi: 10.1093/nar/gkq455. Epub 2010 May 28
[PubMed PMID: 20511593]
[26]
Maciejowski J, Li Y, Bosco N, Campbell PJ, de Lange T. Chromothripsis and Kataegis Induced by Telomere Crisis. Cell. 2015 Dec 17:163(7):1641-54. doi: 10.1016/j.cell.2015.11.054. Epub
[PubMed PMID: 26687355]
[27]
Wilson R, Espinosa-Diez C, Kanner N, Chatterjee N, Ruhl R, Hipfinger C, Advani SJ, Li J, Khan OF, Franovic A, Weis SM, Kumar S, Coussens LM, Anderson DG, Chen CC, Cheresh DA, Anand S. MicroRNA regulation of endothelial TREX1 reprograms the tumour microenvironment. Nature communications. 2016 Nov 25:7():13597. doi: 10.1038/ncomms13597. Epub 2016 Nov 25
[PubMed PMID: 27886180]
[28]
Erdal E, Haider S, Rehwinkel J, Harris AL, McHugh PJ. A prosurvival DNA damage-induced cytoplasmic interferon response is mediated by end resection factors and is limited by Trex1. Genes & development. 2017 Feb 15:31(4):353-369. doi: 10.1101/gad.289769.116. Epub 2017 Mar 9
[PubMed PMID: 28279982]
[29]
Namjou B,Kothari PH,Kelly JA,Glenn SB,Ojwang JO,Adler A,Alarcón-Riquelme ME,Gallant CJ,Boackle SA,Criswell LA,Kimberly RP,Brown E,Edberg J,Stevens AM,Jacob CO,Tsao BP,Gilkeson GS,Kamen DL,Merrill JT,Petri M,Goldman RR,Vila LM,Anaya JM,Niewold TB,Martin J,Pons-Estel BA,Sabio JM,Callejas JL,Vyse TJ,Bae SC,Perrino FW,Freedman BI,Scofield RH,Moser KL,Gaffney PM,James JA,Langefeld CD,Kaufman KM,Harley JB,Atkinson JP, Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes and immunity. 2011 Jun;
[PubMed PMID: 21270825]
[30]
Lee-Kirsch MA, Chowdhury D, Harvey S, Gong M, Senenko L, Engel K, Pfeiffer C, Hollis T, Gahr M, Perrino FW, Lieberman J, Hubner N. A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. Journal of molecular medicine (Berlin, Germany). 2007 May:85(5):531-7
[PubMed PMID: 17440703]
[31]
Rice G, Newman WG, Dean J, Patrick T, Parmar R, Flintoff K, Robins P, Harvey S, Hollis T, O'Hara A, Herrick AL, Bowden AP, Perrino FW, Lindahl T, Barnes DE, Crow YJ. Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. American journal of human genetics. 2007 Apr:80(4):811-5
[PubMed PMID: 17357087]
[32]
Paradis C, Cadieux-Dion M, Meloche C, Gravel M, Paradis J, Des Roches A, Leclerc G, Cossette P, Begin P. TREX-1-Related Disease Associated with the Presence of Cryofibrinogenemia. Journal of clinical immunology. 2019 Jan:39(1):118-125. doi: 10.1007/s10875-018-0584-x. Epub 2019 Jan 26
[PubMed PMID: 30685859]
[33]
Kavanagh D,Spitzer D,Kothari PH,Shaikh A,Liszewski MK,Richards A,Atkinson JP, New roles for the major human 3'-5' exonuclease TREX1 in human disease. Cell cycle (Georgetown, Tex.). 2008 Jun 15;
[PubMed PMID: 18583934]
[34]
Ramantani G, Kohlhase J, Hertzberg C, Innes AM, Engel K, Hunger S, Borozdin W, Mah JK, Ungerath K, Walkenhorst H, Richardt HH, Buckard J, Bevot A, Siegel C, von Stülpnagel C, Ikonomidou C, Thomas K, Proud V, Niemann F, Wieczorek D, Häusler M, Niggemann P, Baltaci V, Conrad K, Lebon P, Lee-Kirsch MA. Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutières syndrome. Arthritis and rheumatism. 2010 May:62(5):1469-77. doi: 10.1002/art.27367. Epub
[PubMed PMID: 20131292]
[35]
Crow YJ, Manel N. Aicardi-Goutières syndrome and the type I interferonopathies. Nature reviews. Immunology. 2015 Jul:15(7):429-40. doi: 10.1038/nri3850. Epub 2015 Jun 5
[PubMed PMID: 26052098]
[36]
Crow YJ, Jackson AP, Roberts E, van Beusekom E, Barth P, Corry P, Ferrie CD, Hamel BC, Jayatunga R, Karbani G, Kálmánchey R, Kelemen A, King M, Kumar R, Livingstone J, Massey R, McWilliam R, Meager A, Rittey C, Stephenson JB, Tolmie JL, Verrips A, Voit T, van Bokhoven H, Brunner HG, Woods CG. Aicardi-Goutières syndrome displays genetic heterogeneity with one locus (AGS1) on chromosome 3p21. American journal of human genetics. 2000 Jul:67(1):213-21
[PubMed PMID: 10827106]
[37]
Crow YJ,Black DN,Ali M,Bond J,Jackson AP,Lefson M,Michaud J,Roberts E,Stephenson JB,Woods CG,Lebon P, Cree encephalitis is allelic with Aicardi-Goutiéres syndrome: implications for the pathogenesis of disorders of interferon alpha metabolism. Journal of medical genetics. 2003 Mar;
[PubMed PMID: 12624136]
[38]
Lee-Kirsch MA, Gong M, Chowdhury D, Senenko L, Engel K, Lee YA, de Silva U, Bailey SL, Witte T, Vyse TJ, Kere J, Pfeiffer C, Harvey S, Wong A, Koskenmies S, Hummel O, Rohde K, Schmidt RE, Dominiczak AF, Gahr M, Hollis T, Perrino FW, Lieberman J, Hübner N. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nature genetics. 2007 Sep:39(9):1065-7
[PubMed PMID: 17660818]
[39]
Beltoise AS, Audouin-Pajot C, Lucas P, Tournier E, Rice GI, Crow YJ, Mazereeuw-Hautier J. [Familial chilblain lupus: Four cases spanning three generations]. Annales de dermatologie et de venereologie. 2018 Nov:145(11):683-689. doi: 10.1016/j.annder.2018.07.014. Epub 2018 Sep 11
[PubMed PMID: 30217686]
Level 3 (low-level) evidence
[40]
Chou HF, Wu YH, Ho CS, Kao YH. Clinical study of children with cryofibrinogenemia: a retrospective study from a single center. Pediatric rheumatology online journal. 2018 Apr 24:16(1):31. doi: 10.1186/s12969-018-0249-6. Epub 2018 Apr 24
[PubMed PMID: 29690915]
Level 2 (mid-level) evidence
[41]
Saito R,Nozaki H,Kato T,Toyoshima Y,Tanaka H,Tsubata Y,Morioka T,Horikawa Y,Oyanagi K,Morita T,Onodera O,Kakita A, Retinal Vasculopathy With Cerebral Leukodystrophy: Clinicopathologic Features of an Autopsied Patient With a Heterozygous TREX 1 Mutation. Journal of neuropathology and experimental neurology. 2019 Feb 1;
[PubMed PMID: 30561700]
[42]
Yan N, Regalado-Magdos AD, Stiggelbout B, Lee-Kirsch MA, Lieberman J. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nature immunology. 2010 Nov:11(11):1005-13. doi: 10.1038/ni.1941. Epub 2010 Sep 26
[PubMed PMID: 20871604]
[43]
Wheeler LA, Trifonova RT, Vrbanac V, Barteneva NS, Liu X, Bollman B, Onofrey L, Mulik S, Ranjbar S, Luster AD, Tager AM, Lieberman J. TREX1 Knockdown Induces an Interferon Response to HIV that Delays Viral Infection in Humanized Mice. Cell reports. 2016 May 24:15(8):1715-27. doi: 10.1016/j.celrep.2016.04.048. Epub 2016 May 12
[PubMed PMID: 27184854]